AR072792A1 - DERIVADOS DE PIRROLOPIRIDINILPIRIMIDIN-2-IL-AMINA, PROCEDIMIENTO DE PREPARACIoN Y COMPOSICIONES FARMACEUTICAS - Google Patents
DERIVADOS DE PIRROLOPIRIDINILPIRIMIDIN-2-IL-AMINA, PROCEDIMIENTO DE PREPARACIoN Y COMPOSICIONES FARMACEUTICASInfo
- Publication number
- AR072792A1 AR072792A1 ARP090102492A ARP090102492A AR072792A1 AR 072792 A1 AR072792 A1 AR 072792A1 AR P090102492 A ARP090102492 A AR P090102492A AR P090102492 A ARP090102492 A AR P090102492A AR 072792 A1 AR072792 A1 AR 072792A1
- Authority
- AR
- Argentina
- Prior art keywords
- atoms
- het
- hal
- cycloalkyl
- mono
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000004429 atom Chemical group 0.000 abstract 4
- 125000004432 carbon atom Chemical group C* 0.000 abstract 4
- -1 1 -hydroxy-cyclopentan-1-yl Chemical group 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 101100134922 Gallus gallus COR5 gene Proteins 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 125000002619 bicyclic group Chemical group 0.000 abstract 1
- 230000004663 cell proliferation Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Los compuestos de la formula (1) en donde R1 es H o A, R2 es A, Hal, CN, (CH2)nCONH(CH2)pAr, -C(OH)R5-Ar, -[C(R5)2]n-Ar, [C(R5)2]n-Het, -[C(R5)2]n-cicloalquilo, -NR5A, -NR5Ar, NR5Het, -[C(R5)2]mN(R5)2, 1-hidroxi-ciclopentan-1-ilo o 1-hidroxiciclohexan-1-ilo, R3 es H, R5, -[C(R5)2]n-Ar, -[C(R5)2]n-Het, -[C(R5)2]n-cicloalquilo, R4 es H, Het-, Ar-, -R5, -OR5, -[C(R6)2]nC(O)N(R6)2, CO-Het u O(CH2)pHet1, R5 es H, A o cicloalquilo, R6 es H o A', A' es alquilo no ramificado o ramificado con 1-10 átomos de C, en donde 1-7 átomos de H pueden estar reemplazados por F, cicloalquilo es alquilo cíclico con 3-7 átomos de C, que puede estar adicionalmente sustituido con alquilo con 1-6 átomos de C, A es alquilo no ramificado o ramificado con 1-10 átomos de C, en donde uno o dos grupos CH y/o CH2 pueden estar reemplazados por átomos de N, O, S y/o por grupos -CH=CH y/o también 1-7 átomos de H pueden estar reemplazados por F, X es NH, O, S o SO2, Ar es fenilo no sustituido o mono-, di- o trisustituido con Hal, A, OR5, N(R5)2, NO2, CN, COOR5, CON(R5)2, NR5COA, NR5SO2A, COR5, SO2N(R5)2 y/o S(O)pA, Het es un heterociclo saturado, insaturado o aromático mono- o bicíclico no sustituido o mono- o disustituido con Hal, A, OR5, (CH2)pN(R5)2, NO2, CN, (CH2)pCOOR5, (CH2)pCON(R5)2, NR5COA, (CH2)pHet1, (CH2)pCOHet1, NR5SO2A, COR5, SO2NR5 y/o S(O)pA con 1a 4 átomos de N y/u O y/o S, Het1 es un heterociclo saturado no sustituido o mono- o disustituido con A, S(O)pA y/o COA con 1 a 4 átomos de N, O y o S, Hal es F, Cl, Br o I, m es 1, 2, 3, o 4, n es 0, 1, 2, 3, o 4, p es 0, 1 o 2, así como sus sales, tautomeros y estereoisomeros farmacéuticamente aceptables, incluyendo sus mezclas en todas las proporciones. Son inhibidores de la proliferacion celular / vitalidad celular y se pueden emplear para el tratamiento de tumores.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102008031517A DE102008031517A1 (de) | 2008-07-03 | 2008-07-03 | Pyrrolopyridinyl-pyrimidin-2-yl-amin-derivate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR072792A1 true AR072792A1 (es) | 2010-09-22 |
Family
ID=40849173
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP090102492A AR072792A1 (es) | 2008-07-03 | 2009-07-03 | DERIVADOS DE PIRROLOPIRIDINILPIRIMIDIN-2-IL-AMINA, PROCEDIMIENTO DE PREPARACIoN Y COMPOSICIONES FARMACEUTICAS |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US8420820B2 (es) |
| EP (1) | EP2291375B1 (es) |
| JP (2) | JP5587874B2 (es) |
| KR (1) | KR20110027835A (es) |
| CN (1) | CN102056926B (es) |
| AR (1) | AR072792A1 (es) |
| AU (1) | AU2009266090B2 (es) |
| BR (1) | BRPI0913832A2 (es) |
| CA (1) | CA2729725C (es) |
| DE (1) | DE102008031517A1 (es) |
| EA (1) | EA201100125A1 (es) |
| ES (1) | ES2564204T3 (es) |
| IL (1) | IL210406A (es) |
| MX (1) | MX2010013919A (es) |
| WO (1) | WO2010000364A1 (es) |
| ZA (1) | ZA201100876B (es) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102008031517A1 (de) * | 2008-07-03 | 2010-01-07 | Merck Patent Gmbh | Pyrrolopyridinyl-pyrimidin-2-yl-amin-derivate |
| DE102009060174A1 (de) * | 2009-12-23 | 2011-06-30 | Merck Patent GmbH, 64293 | Pyrrolopyridinyl-pyrimidin-2-yl-amin-derivate |
| DK2558446T5 (da) | 2010-04-16 | 2019-12-09 | Ac Immune Sa | Nye forbindelser til behandling af sygdomme associerede med amyloid- eller amyloidlignende proteiner |
| CN102985422A (zh) * | 2010-05-12 | 2013-03-20 | Abbvie公司 | 激酶的吡咯并吡啶和吡咯并嘧啶抑制剂 |
| DE102010050558A1 (de) | 2010-11-05 | 2012-05-10 | Merck Patent Gmbh | 1H-Pyrrolo[2,3-b]pyridinderivate |
| DE102010053347A1 (de) * | 2010-12-03 | 2012-06-06 | Merck Patent Gmbh | 3-Hetaryl-substituierte Pyrrolo[2,3-b] pyridin-derivative als PDK1-Inhibitoren |
| DE102011009961A1 (de) * | 2011-02-01 | 2012-08-02 | Merck Patent Gmbh | 7-Azaindolderivate |
| DE102011105469A1 (de) * | 2011-06-24 | 2012-12-27 | Merck Patent Gmbh | 7-Azaindolderivate |
| AP3902A (en) | 2012-06-29 | 2016-11-17 | Pfizer | Novel 4-(substituted-amino)-7H-pyrrolo[2,3-d]pyrimidines as LRRK2 inhibitors |
| MX2015012456A (es) * | 2013-03-15 | 2016-02-03 | Plexxikon Inc | Compuestos heterociclicos y usos de los mismos. |
| US20140303121A1 (en) | 2013-03-15 | 2014-10-09 | Plexxikon Inc. | Heterocyclic compounds and uses thereof |
| JP6487921B2 (ja) | 2013-12-17 | 2019-03-20 | ファイザー・インク | ＬＲＲＫ２阻害薬としての新規の３，４−二置換−１Ｈ−ピロロ［２，３−ｂ］ピリジンおよび４，５−二置換−７Ｈ−ピロロ［２，３−ｃ］ピリダジン |
| MX2017009571A (es) * | 2015-01-23 | 2018-09-27 | Aclaris Therapeutics Inc | Inhibidores heterociclicos de itk para el tratamiento de la inflamacion y cancer. |
| CN106432246B (zh) * | 2015-08-05 | 2020-07-07 | 广东东阳光药业有限公司 | 杂芳化合物及其在药物中的应用 |
| MX2018003215A (es) | 2015-09-14 | 2018-06-08 | Pfizer | Derivados de imidazo[4,5-c]quinolina e imidazo[4,5-c][1,5]naftirid ina novedosos como inhibidores de lrrk2. |
| GB201704965D0 (en) | 2017-03-28 | 2017-05-10 | Astex Therapeutics Ltd | Pharmaceutical compounds |
| EP3694855A1 (en) | 2017-10-13 | 2020-08-19 | Plexxikon Inc. | Solid forms of a compound for modulating kinases |
| EP3706086A4 (en) | 2017-10-31 | 2021-07-21 | Alise Devices, S.L. | PROCESS FOR MANUFACTURING PERSONALIZED DOCUMENTARY SECURITY OPTICAL ELEMENTS AND ELEMENT THUS OBTAINED |
| JP7018333B2 (ja) | 2018-03-08 | 2022-02-10 | 大林道路株式会社 | 複装式カッター |
| IL278142B2 (en) | 2018-04-24 | 2023-11-01 | Merck Patent Gmbh | Antiproliferative compounds and their uses |
| SG11202104404XA (en) * | 2018-11-16 | 2021-05-28 | California Inst Of Techn | Erk inhibitors and uses thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5747469A (en) | 1991-03-06 | 1998-05-05 | Board Of Regents, The University Of Texas System | Methods and compositions comprising DNA damaging agents and p53 |
| GB9904387D0 (en) | 1999-02-25 | 1999-04-21 | Pharmacia & Upjohn Spa | Antitumour synergistic composition |
| GB0308466D0 (en) | 2003-04-11 | 2003-05-21 | Novartis Ag | Organic compounds |
| RU2403252C2 (ru) | 2004-03-30 | 2010-11-10 | Вертекс Фармасьютикалз Инкорпорейтед | Азаиндолы, полезные в качестве ингибиторов jak и других протеинкиназ |
| CA2608333A1 (en) * | 2005-05-16 | 2006-11-23 | Irm Llc | Pyrrolopyridine derivatives as protein kinase inhibitors |
| DE102006012617A1 (de) * | 2006-03-20 | 2007-09-27 | Merck Patent Gmbh | 4-(Pyrrolopyridinyl)-pyrimidinyl-2-amin-derivate |
| DE102007028515A1 (de) * | 2007-06-21 | 2008-12-24 | Merck Patent Gmbh | 6-(Pyrrolopyridinyl)-pyrimidinyl-2-amin-derivate |
| DE102008031517A1 (de) * | 2008-07-03 | 2010-01-07 | Merck Patent Gmbh | Pyrrolopyridinyl-pyrimidin-2-yl-amin-derivate |
-
2008
- 2008-07-03 DE DE102008031517A patent/DE102008031517A1/de not_active Withdrawn
-
2009
- 2009-06-04 MX MX2010013919A patent/MX2010013919A/es not_active Application Discontinuation
- 2009-06-04 BR BRPI0913832A patent/BRPI0913832A2/pt not_active IP Right Cessation
- 2009-06-04 ES ES09772064.3T patent/ES2564204T3/es active Active
- 2009-06-04 US US13/002,168 patent/US8420820B2/en active Active
- 2009-06-04 CN CN2009801210428A patent/CN102056926B/zh not_active Expired - Fee Related
- 2009-06-04 EA EA201100125A patent/EA201100125A1/ru unknown
- 2009-06-04 JP JP2011515149A patent/JP5587874B2/ja not_active Expired - Fee Related
- 2009-06-04 WO PCT/EP2009/004013 patent/WO2010000364A1/de active Application Filing
- 2009-06-04 CA CA2729725A patent/CA2729725C/en not_active Expired - Fee Related
- 2009-06-04 AU AU2009266090A patent/AU2009266090B2/en not_active Ceased
- 2009-06-04 KR KR1020117002711A patent/KR20110027835A/ko not_active Application Discontinuation
- 2009-06-04 EP EP09772064.3A patent/EP2291375B1/de not_active Not-in-force
- 2009-07-03 AR ARP090102492A patent/AR072792A1/es unknown
-
2010
- 2010-12-30 IL IL210406A patent/IL210406A/en active IP Right Grant
-
2011
- 2011-02-02 ZA ZA2011/00876A patent/ZA201100876B/en unknown
-
2014
- 2014-07-24 JP JP2014150294A patent/JP5955902B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE102008031517A1 (de) | 2010-01-07 |
| IL210406A0 (en) | 2011-03-31 |
| IL210406A (en) | 2014-11-30 |
| EP2291375B1 (de) | 2016-01-06 |
| KR20110027835A (ko) | 2011-03-16 |
| CN102056926B (zh) | 2013-10-16 |
| EP2291375A1 (de) | 2011-03-09 |
| CA2729725A1 (en) | 2010-01-07 |
| CN102056926A (zh) | 2011-05-11 |
| US20110218198A1 (en) | 2011-09-08 |
| JP5587874B2 (ja) | 2014-09-10 |
| CA2729725C (en) | 2016-11-08 |
| BRPI0913832A2 (pt) | 2015-10-20 |
| WO2010000364A8 (de) | 2011-01-06 |
| AU2009266090B2 (en) | 2014-04-03 |
| US8420820B2 (en) | 2013-04-16 |
| ES2564204T3 (es) | 2016-03-18 |
| ZA201100876B (en) | 2011-10-26 |
| EA201100125A1 (ru) | 2011-08-30 |
| JP2014240397A (ja) | 2014-12-25 |
| JP2011526260A (ja) | 2011-10-06 |
| JP5955902B2 (ja) | 2016-07-20 |
| AU2009266090A1 (en) | 2010-01-07 |
| WO2010000364A1 (de) | 2010-01-07 |
| MX2010013919A (es) | 2011-02-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR072792A1 (es) | DERIVADOS DE PIRROLOPIRIDINILPIRIMIDIN-2-IL-AMINA, PROCEDIMIENTO DE PREPARACIoN Y COMPOSICIONES FARMACEUTICAS | |
| AR076006A1 (es) | Compuestos heterociclicos inhibidores de autotaxina utiles para el tratamiento de tumores, proceso para prepararlos y medicamentos que los contienen. | |
| AR066543A1 (es) | Derivados de piridazinona | |
| AR066770A1 (es) | Derivados de piridazinona | |
| AR056986A1 (es) | Aza heterociclos como inhibidores de quinasas. procedimiento de obtencion y composiciones farmaceuticas | |
| AR078313A1 (es) | Derivados de piridinil-imidazolona inhibidores de quinasas pi3k,composiciones farmaceuticas que los comprenden, metodo para prepararlos y uso de los mismos en el tratamiento de enfermedades autoinmunes e inflamatorias, entre otras | |
| AR057214A1 (es) | Derivados de piridazinona como inhibidores, reguladores o moduladores de quinasas. | |
| AR067081A1 (es) | Derivados de pirrolo[2,3-b]piridin-pirimidina,proceso de preparacion, medicamentos que los contienen y usos de los mismos para el tratamiento de tumores cancerigenos y metastasis tumorales. | |
| AR083670A1 (es) | DERIVADOS DE 7-([1,2,3]TRIAZOL-4-IL)-PIRROLO[2,3-b]PIRAZINA UTILES COMO INHIBIDORES DE LA PROLIFERACION CELULAR, COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN Y PROCEDIMIENTO PARA PREPARARLOS | |
| AR068659A1 (es) | Derivados de imidazol inhibidores de autotaxina | |
| AR074418A1 (es) | Compuestos de benzonaftiridina, procedimiento de preparacion y su uso en el tratamiento de tumores | |
| BRPI0713544B8 (pt) | estrutura de cristal de solvato de (s)-propileno glicol de fórmula ia | |
| BR112013026345A2 (pt) | composto, composição farmacêutica, uso de um composto, e, método para tratar um paciente infectado com hcv | |
| CO6170361A2 (es) | Composiciones y metodos para modular receptores de c-kit y pdgfr | |
| AR073055A1 (es) | Derivados biciclicos de triazol | |
| AR076750A1 (es) | Derivados de 3-((1,2,3) triazol -4-il)- pirrolo (2,3-b) piridina | |
| AR069843A1 (es) | Derivados de piridazinona, procedimiento para preparar dichos compuestos, composiciones farmaceuticas y usos de los mismos para preparar un medicamento | |
| AR077567A1 (es) | Derivados de aminopiridina | |
| AR055772A1 (es) | Aza -heterociclos como inhibidores de quinasas, preparacion de los compuestos y medicamento preparado en base al compuesto | |
| AR071208A1 (es) | Derivados de piridazinona | |
| AR082726A1 (es) | Derivados de triazolopirazina | |
| AR072192A1 (es) | Derivados de tiazolil-piperidina | |
| AR083402A1 (es) | Pirrolidinonas como inhibidores de metap-2 | |
| AR082722A1 (es) | Derivados de pirimidina | |
| PE20090880A1 (es) | Compuestos heterociclicos como inhibidores de fosfatidilinositol 3-cinasa |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |